Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $1.195 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 10/24/2019 04:51:37 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-24-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-23-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-22-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-21-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-19-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-17-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-15-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-11-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-10-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-09-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-08-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-07-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-04-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-03-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-02-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 10-01-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 09-30-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 09-27-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 09-26-2019 |
$ | $N/A | $1.195 | $N/A | $N/A | 0 | 09-25-2019 |
News, Short Squeeze, Breakout and More Instantly...
SAN JOSE, Calif. , Aug. 8, 2019 /PRNewswire/ -- Intermolecular, Inc. (Nasdaq: IMI), the trusted partner for advanced materials innovation, today reported results for its second quarter ended June 30, 2019 . Second Quarter of 2019 Financial Results Revenue for the second quarte...
SAN JOSE, Calif. , Aug. 1, 2019 /PRNewswire/ -- Intermolecular, Inc. (NASDAQ: IMI), the trusted partner for advanced materials innovation, today announced Intermolecular Senior Vice President of Programs and Operations Milind Weling , will be leading a special session, 3D XPoint: ...
SAN JOSE, Calif. , July 17, 2019 /PRNewswire/ -- Intermolecular, Inc. (NASDAQ: IMI) announced today that the stockholders of Intermolecular have approved the previously announced proposed acquisition of all outstanding shares of common stock of Intermolecular by Merck KGaA,...